Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Urology
Published in: BMC Urology 1/2018

Open Access 01-12-2018 | Case report

Daily tadalafil for the chronic phase of stuttering priapism: a case report

Authors: Paolo Massenio, Nicola D’Altilia, Francesca Sanguedolce, Giuseppe Carrieri, Luigi Cormio

Published in: BMC Urology | Issue 1/2018

Login to get access

Abstract

Background

Recurrent (stuttering) ischemic priapism is a challenging clinical condition. Frequent recurrences result in frequent hospital admissions whereas treatment with a shunting procedure often results in erectile dysfunction.

Case presentation

A 22-year-old man with stuttering idiopathic priapism developed erectile dysfunction (IIEF-5 score 12) following a Winter’s shunt; he was given tadalafil, 5 mg/daily, for 6 months. This treatment resulted in progressive restoration of erectile function in the 6 months following the shunt as well as in preventing recurrence of priapic episodes over a 24-month follow-up.

Conclusions

This is the first report in literature of chronic treatment of stuttering priapism with a phosphodiesterase-5 inhibitor being able not only to prevent recurrent priapic episodes but also to restore erectile function following a Winter’s shunt.
Literature
1.
Broderick GA, Harkaway R. Pharmacologic erection: time-dependent changes in the corporal environment. Int J Impot Res. 1994;6:9.PubMed
2.
Grayhack JT, Mccullough W, O’conor VJ Jr, Trippel O. Venous bypass to control priapism. Investig Urol. 1964;1:509–13.
3.
Winter CC. Priapism treated by modification of creation of fistulas between glans penis and corpora cavernosa. J Urol. 1979;121:743–4.CrossRefPubMed
4.
Sadeghi-Nejad H, Seftel AD. The etiology, diagnosis, and treatment of priapism: review of the American Foundation for Urologic Disease Consensus Panel Report. Curr Urol Rep. 2002;3(6):492–8.CrossRefPubMed
5.
Levey HR, et al. Medical management of ischemic stuttering priapism: a contemporary review of the literature. Asian J Androl. 2012;14(1):156–63.CrossRefPubMed
6.
Pria 2016, Hudnall, et al. Advance in the understanding of priapism. Transl Androl Urol. 2017;6(2):199–206.CrossRef
7.
El-Bahnasawy MS, Dawood A, Farouk A. Low- flow priapism: risk factors for erectile dysfunction. BJU Int. 2002;89(3):285–90.CrossRefPubMed
8.
9.
10.
Bochinski DJ, Deng DY, Lue TF. The treatment of priapism- when and how? Int J Imp Res. 2003;15(Suppl 5):S56–S90.
11.
Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, et al. Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010;7:476–500.CrossRefPubMed
12.
Mantadakis E, Cavender JD, Rogers ZR, Ewalt DH, Buchanan GR. Prevalence of priapism in children and adolescents with sickle cell anemais. J Pediatr Hematol Oncol. 1999;21:518–22.CrossRefPubMed
13.
Bivalacqua TJ, Burnett AL. Priapism. In: Graham SD, Glen JF, editors. Glenn’s urologic surgery. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2010. p. 487–91.
14.
Bivalacqua TJ, Burnett AL. Priapism: new concepts in pathophysiology and new treatment strategies. Curr Urol Rep. 2006;7:497–502.CrossRefPubMed
15.
Champion HC, Bivalacqua TJ, Takimoto E, Kass DA, Burnett AL. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci U S A. 2005;102:1661–6.CrossRefPubMedPubMedCentral
16.
Bivalacqua TJ, Musicki B, Hsu LL, Gladwin MT, Burnett AL, et al. Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism. J Sex Med. 2009;6:2494–504.CrossRefPubMedPubMedCentral
17.
Bialecki ES, Bridges KR. Sildenafil relieves priapism in patients with sickle cell disease. Am J Med. 2002;113:252.CrossRefPubMed
18.
Burnett AL, Bivalacqua TJ, Champion HC, Musicki B. Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. J Sex Med. 2006;3:1077–84.CrossRefPubMed
19.
Bivalacqua TJ, Musicki B, Champion HC, Burnett AL. Phosphodiesterase type 5 inhibitor therapy for priapism. In: Carson IIICC, Kirby RS, Goldstein I, Wyllie MG, editors. Textbook of erectile dysfunction. 2nd ed. New York: Informa HealthCare; 2009. p. 428–33.
20.
Burnett AL, Bivalacqua TJ. Priapism: current principles and practice. Urol Clin North Am. 2007;34:631–42.CrossRefPubMed
21.
Champion HC, et al. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci U S A. 2005;102(5):1661–6.CrossRefPubMedPubMedCentral
22.
Metadata
Title
Daily tadalafil for the chronic phase of stuttering priapism: a case report
Authors
Paolo Massenio
Nicola D’Altilia
Francesca Sanguedolce
Giuseppe Carrieri
Luigi Cormio
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2018
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-018-0368-x

Other articles of this Issue 1/2018

BMC Urology 1/2018 Go to the issue

Research article

Kidney stone formers have more renal parenchymal crystals than non-stone formers, particularly in the papilla region

Research article

Silodosin 8 mg improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: results from an explorative clinical study

Research article

Surgical management of urolithiasis – a systematic analysis of available guidelines

Research article

Changes in renal papillary density after hydration therapy in calcium stone formers

Research article

Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study

Research article

Detection of micro-metastases by flow cytometry in lymph nodes from patients with penile cancer